---
figid: PMC4951290__oncotarget-07-18309-g001
figtitle: Nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic
  phenotype of cancer cells
organisms:
- NA
pmcid: PMC4951290
filename: oncotarget-07-18309-g001.jpg
figlink: /pmc/articles/PMC4951290/figure/F1/
number: F1
caption: 'Green, name of the enzymes down-regulated by PE5; blue, metabolites that
  are the main source of energy for cancer cells depending on their status; blue arrows,
  catabolic pathways; blue dashed arrows, potential gluconeogenesis not still proved
  in cancer cells (see text for more details); red arrows, biosynthetic pathways critical
  for cancer cell grow and division; PPP, pentose phosphate pathway; TCA, tricarboxylic
  acid; G6P, glucose-6-phosphate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; 2PG,
  2-phosphoglycerate; 3PG, 3-phosphoglycerate; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme
  A; R5P, ribose-5-phosphate. Enzymes: ACACA, acetyl-CoA carboxylase alpha; ACAT,
  acetyl-CoA acetyltransferase; ACL, ATP citrate lyase; ASAH1, N-acylsphingosine amidohydrolase
  (acid ceramidase) 1; DHCR24, 24-dehydrocholesterol reductase; ENO1, enolase 1, (alpha);
  FASN, fatty acid synthase; GPT, alanine aminotransferase; G6PD, glucose-6-phosphate
  dehydrogenase; HADHA, hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA
  hydratase (trifunctional protein), alpha subunit; HMGCR, HMG-CoA reductase; HMGCS,
  HMG-CoA synthase; IDH2, isocitrate dehydrogenase 2 (NADP+), mitochondrial; LDHA,
  lactate dehydrogenase A; LPL, lipoprotein lipase; MDH1, malate dehydrogenase 1,
  NAD (soluble); MDH2, malate dehydrogenase 2, NAD (mitochondrial); ME1, malic enzyme
  1, NADP+-dependent, cytosolic; ME3, malic enzyme 3, NADP+-dependent, mitochondrial;
  MSMO1, methylsterol monooxygenase 1; PC, pyruvate carboxylase; PCCB, propionyl CoA
  carboxylase, beta polypeptide; PCK2, phophoenolpyruvate carboxykinase 2 (mitochondrial);
  PDH, pyruvate dehydrogenase complex; PGAM1, phosphoglycerate mutase 1 (brain); PGM1,
  phosphoglucomutase 1, PHGDH, phosphoglycerate dehydrogenase; PK, pyruvate kinase;
  PSAT1, phosphoserine aminotransferase 1; SPTLC3, serine palmitoyltransferase, long
  chain base subunit 3; TM7SF2, transmembrane 7 superfamily member 2.'
papertitle: A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic
  phenotype of cancer cells.
reftext: Anna Vert, et al. Oncotarget. 2016 Apr 5;7(14):18309-18324.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9443137
figid_alias: PMC4951290__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4951290__F1
ndex: 43b762ae-deff-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4951290__oncotarget-07-18309-g001.html
  '@type': Dataset
  description: 'Green, name of the enzymes down-regulated by PE5; blue, metabolites
    that are the main source of energy for cancer cells depending on their status;
    blue arrows, catabolic pathways; blue dashed arrows, potential gluconeogenesis
    not still proved in cancer cells (see text for more details); red arrows, biosynthetic
    pathways critical for cancer cell grow and division; PPP, pentose phosphate pathway;
    TCA, tricarboxylic acid; G6P, glucose-6-phosphate; OAA, oxaloacetate; PEP, phosphoenolpyruvate;
    2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme
    A; R5P, ribose-5-phosphate. Enzymes: ACACA, acetyl-CoA carboxylase alpha; ACAT,
    acetyl-CoA acetyltransferase; ACL, ATP citrate lyase; ASAH1, N-acylsphingosine
    amidohydrolase (acid ceramidase) 1; DHCR24, 24-dehydrocholesterol reductase; ENO1,
    enolase 1, (alpha); FASN, fatty acid synthase; GPT, alanine aminotransferase;
    G6PD, glucose-6-phosphate dehydrogenase; HADHA, hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA
    thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit; HMGCR, HMG-CoA
    reductase; HMGCS, HMG-CoA synthase; IDH2, isocitrate dehydrogenase 2 (NADP+),
    mitochondrial; LDHA, lactate dehydrogenase A; LPL, lipoprotein lipase; MDH1, malate
    dehydrogenase 1, NAD (soluble); MDH2, malate dehydrogenase 2, NAD (mitochondrial);
    ME1, malic enzyme 1, NADP+-dependent, cytosolic; ME3, malic enzyme 3, NADP+-dependent,
    mitochondrial; MSMO1, methylsterol monooxygenase 1; PC, pyruvate carboxylase;
    PCCB, propionyl CoA carboxylase, beta polypeptide; PCK2, phophoenolpyruvate carboxykinase
    2 (mitochondrial); PDH, pyruvate dehydrogenase complex; PGAM1, phosphoglycerate
    mutase 1 (brain); PGM1, phosphoglucomutase 1, PHGDH, phosphoglycerate dehydrogenase;
    PK, pyruvate kinase; PSAT1, phosphoserine aminotransferase 1; SPTLC3, serine palmitoyltransferase,
    long chain base subunit 3; TM7SF2, transmembrane 7 superfamily member 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LPL
  - LCP1
  - G6PD
  - UBL4A
  - PGM1
  - DECR1
  - PHGDH
  - SPTLC3
  - PGAM1
  - PGAM4
  - ENO1
  - FASN
  - PAEP
  - PREP
  - PTPN22
  - LDHA
  - MDH1
  - ME1
  - PCDHB16
  - ACAT1
  - CES1
  - SOAT1
  - ACLY
  - HMGCS1
  - HMGCR
  - ME3
  - PCDHGA5
  - DHCR24
  - TM7SF2
  - MSMO1
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - PCK2
  - HADHA
  - PCCB
  - MDH2
  - GPT
  - DPAGT1
  - IDH2
  - acetoacetyl-CoA
  - R-acyl-CoA
  - alanine
  - cholesterol
  - fatty acids
  - glucose
  - glutamine
  - glycine
  - isocitrate
  - mevalonate
  - pyruvate
  - serine
  - sphingolipids
  - triglycerides
  - glutamate
  - lactate
---
